Study Effect of VIA-2291 on Vascular Inflammation

Clinical trial NCT00358826 · COMPLETED

Trial details

NCT number: NCT00358826
Sponsor: Tallikut Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2006-07-01
Primary completion: 2008-08-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.